95 related articles for article (PubMed ID: 31652161)
1. Asymptomatic Metastasis to Thyroid Cartilage Detected by 18F-Choline and 64Cu-PSMA PET/CT as a Single Site of Disease Relapse in a Patient With Castration-Resistant Prostate Carcinoma.
Annovazzi A; Faiella A; Pescarmona E; Sanguineti G; Sciuto R
Clin Nucl Med; 2020 Mar; 45(3):214-216. PubMed ID: 31652161
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma.
Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
Clin Nucl Med; 2018 Jul; 43(7):486-491. PubMed ID: 29688951
[TBL] [Abstract][Full Text] [Related]
4. Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer.
Nozaki K; Kawai T; Fujimura T; Matsui H; Teshima T; Oshina T; Takahashi A; Sato Y; Yamada D; Azuma T; Hotta M; Nakajima K; Nakayama H; Minamimoto R; Kume H
Int Urol Nephrol; 2019 Oct; 51(10):1763-1769. PubMed ID: 31325132
[TBL] [Abstract][Full Text] [Related]
5. Soft Tissue Response on 18F-Fluorocholine PET/CT in Metastatic Castrate-Resistant Prostate Cancer Treated With 223Ra-Dichloride: A Possible Abscopal Effect?
Kwee SA; Lim J; Coel MN
Clin Nucl Med; 2017 Nov; 42(11):868-871. PubMed ID: 28872544
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving
Sathekge M; Bruchertseifer F; Vorster M; Lawal IO; Knoesen O; Mahapane J; Davis C; Reyneke F; Maes A; Kratochwil C; Lengana T; Giesel FL; Van de Wiele C; Morgenstern A
J Nucl Med; 2020 Jan; 61(1):62-69. PubMed ID: 31101746
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Algorithm Guided by Sequential 11C-Choline PET/CT in a Patient With Metastatic Castration-Resistant Prostate Cancer.
Garcia Garzon JR; Bassa P; Soler M; Moragas M; Llinares E; Riera E
Clin Nucl Med; 2015 Jul; 40(7):600-1. PubMed ID: 25742237
[TBL] [Abstract][Full Text] [Related]
8. Rare Thyroid Cartilage Metastasis From Breast Cancer Visualized on 18F-NaF PET/CT.
Usmani S; Ahmed N; Ilyas MW; Murad S; Al Kandari F
Clin Nucl Med; 2021 Jan; 46(1):43-44. PubMed ID: 33156044
[TBL] [Abstract][Full Text] [Related]
9. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma.
Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
Clin Nucl Med; 2018 May; 43(5):323-330. PubMed ID: 29485430
[TBL] [Abstract][Full Text] [Related]
10. Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.
Fendler WP; Weber M; Iravani A; Hofman MS; Calais J; Czernin J; Ilhan H; Saad F; Small EJ; Smith MR; Perez PM; Hope TA; Rauscher I; Londhe A; Lopez-Gitlitz A; Cheng S; Maurer T; Herrmann K; Eiber M; Hadaschik B
Clin Cancer Res; 2019 Dec; 25(24):7448-7454. PubMed ID: 31511295
[TBL] [Abstract][Full Text] [Related]
11. Whole-body 18F-fluorocholine (FCH) PET/CT and MRI of the spine for monitoring patients with castration-resistant prostate cancer metastatic to bone: a pilot study.
Balogova S; Zakoun JB; Michaud L; Khalil A; Tassart M; Esteso A; Kerrou K; Huchet V; Carette MF; Lotz JP; Talbot JN
Clin Nucl Med; 2014 Nov; 39(11):951-9. PubMed ID: 25140552
[TBL] [Abstract][Full Text] [Related]
12. 223Ra-Dichloride Response Evaluation Using 18F-Fluciclovine PET/CT and Bone Scintigraphy in a Patient With Castration-Resistant Metastatic Prostate Cancer.
Wang J; Kuker R; Serafini A
Clin Nucl Med; 2020 Nov; 45(11):e486-e488. PubMed ID: 32657864
[TBL] [Abstract][Full Text] [Related]
13. 18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.
Florimonte L; Orunesu E; Castellani M; Longari V; Cortelezzi A
Clin Nucl Med; 2016 May; 41(5):394-6. PubMed ID: 26825195
[TBL] [Abstract][Full Text] [Related]
14. Long-term Survival and Excellent Response to Repeated 177Lu-Prostate-Specific Membrane Antigen 617 Radioligand Therapy in a Patient With Advanced Metastatic Castration-Resistant Prostate Cancer.
Roll W; Bräuer A; Weckesser M; Bögemann M; Rahbar K
Clin Nucl Med; 2018 Oct; 43(10):755-756. PubMed ID: 30036254
[TBL] [Abstract][Full Text] [Related]
15. Metastatic Prostate Cancer With Restored Hormone-Response After Radioligand Therapy With 177Lu-PSMA-617.
Schlenkhoff CD; Knüpfer E; Essler M; Ahmadzadehfar H
Clin Nucl Med; 2016 Jul; 41(7):572-3. PubMed ID: 26909718
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bone metastases by 18F-choline PET/CT in a patient with castration-resistant prostate cancer treated with radium-223.
Scalzi P; Baiocco C; Genovese S; Trevisan A; Sirotova Z; Poti C
Urologia; 2017 Feb; 84(1):61-64. PubMed ID: 27911459
[TBL] [Abstract][Full Text] [Related]
17. Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT.
Lee J; Sato MM; Coel MN; Lee KH; Kwee SA
J Nucl Med; 2016 Jul; 57(7):1058-64. PubMed ID: 26912444
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.
Van den Broeck B; De Maeseneer D; De Gersem R; De Man K
Clin Nucl Med; 2017 Apr; 42(4):e207-e209. PubMed ID: 28134691
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic metastasis to cricoid from prostate carcinoma: an incidental finding detected on 18F-choline PET/CT.
Ng SJ; Sinha AK; Loi HY; Khor LK
Jpn J Radiol; 2015 May; 33(5):298-301. PubMed ID: 25820451
[TBL] [Abstract][Full Text] [Related]
20. Imaging of Prostate Cancer Using
Castellucci P; Ceci F; Fanti S
PET Clin; 2017 Apr; 12(2):137-143. PubMed ID: 28267448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]